Recombinant E. coli Glycolic Acid Fermentation Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The biological production of glycolic acid from inexpensive carbon sources like glucose or sugars is hindered by the complexity and number of biochemical steps in existing methods, necessitating the use of metabolically engineered whole cell catalysts for an industrially feasible process.
Innovation Solution
A method for bioconverting a fermentable carbon source into glycolic acid using a recombinant microorganism modified to attenuate the conversion of glyoxylate to products other than glycolate, by inactivating specific genes involved in glyoxylate metabolism and increasing NADPH availability, allowing direct conversion of carbon sources such as sugars into glycolic acid.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If existing enzymatic conversion methods are used to produce glycolic acid, then glycolic acid can be produced from substrates like glycolonitrile or ethylene glycol, but the process requires multiple enzymatic steps and complex metabolic pathways that are not industrially feasible
Solution Approach 1:
The patent extracts and eliminates unnecessary metabolic pathways by deleting specific genes (aceB, gcl, glcB, eda, glcDEF, aldA) that divert glyoxylate away from glycolate production. This simplifies the metabolic pathway by removing competing reactions and intermediate steps, leaving only the essential glyoxylate-to-glycolate conversion catalyzed by YcdW enzyme, thereby making the process industrially feasible
Solution Approach 2:
The patent segments the metabolic pathway into distinct functional modules: (1) substrate uptake and initial metabolism, (2) glyoxylate formation via TCA cycle, (3) glyoxylate reduction to glycolate by YcdW, and (4) glycolate accumulation. By segmenting and optimizing each module independently through targeted gene modifications, the complex overall process becomes manageable and scalable for industrial production
2Productivity
If glyoxylate is produced as an intermediate in the TCA cycle, then it can be converted to glycolate, but glyoxylate is also converted to other products through multiple competing pathways reducing glycolic acid yield
Solution Approach 1:
The patent converts the harmful effect of glyoxylate diversion to other products into a benefit by strategically deleting the genes responsible for these alternative pathways (aceB for malate synthase, gcl for glyoxylate carboligase, glcB for second malate synthase, eda for aldolase). This forces all glyoxylate flux through the desired YcdW-catalyzed reduction to glycolate, transforming the problem of pathway competition into a solution where the entire glyoxylate pool is productively converted to glycolic acid
Solution Approach 2:
The patent changes the metabolic parameters by modifying gene expression levels and enzyme activities. Specifically, it deletes genes to eliminate competing pathways and overexpresses or optimizes the ycdW gene to maximize glyoxylate reductase activity. This parameter optimization ensures that the biochemical conversion of glyoxylate to glycolate proceeds with maximum efficiency and minimum loss to side products
3Productivity
If multiple genes are inactivated to simplify the metabolic pathway, then glycolic acid production is optimized, but the genetic engineering process becomes more complex
Solution Approach 1:
The patent applies preliminary action by pre-designing and implementing a comprehensive gene deletion strategy before fermentation. All target genes (aceB, gcl, glcB, eda, glcDEF, aldA) are inactivated in the host organism prior to glycolic acid production. This upfront genetic engineering creates a streamlined metabolic pathway that requires no further complex modifications during the production process, simplifying scale-up and industrial implementation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a higher yield of glycolic acid production, making the process more efficient and feasible for industrial applications by optimizing the metabolic pathway of the recombinant microorganism to produce glycolic acid from inexpensive carbon substrates.
Implementation Method 1
a) Fermentation of the microorganism to produce glycolic acid by converting the source of carbon into glycolic acid
Implementation Method 2
Glyoxylate is reduced to glycolate by a NADPH dependent oxidoreductase encoded by the gene ycdW
Data Source
Figure 1
Figure 2
AI summary
The present invention provides a method for the biological production of glyco lic acid from a fermentable carbon source in a microorganism. In one aspect of the present invention, a process for the conversion of glucose to glycolic acid is achieved by the use of a recombinant organism comprising a host E. coli transformed i) to attenuate the glyoxylate consuming pathways to other compounds than glycolate ii) to use an NADPH glyoxylate reductase to convert glyoxylate to glycolate iii) to attenuate the level o f all the glycolate metabolizing enzymes and iv) increase the flux in the glyoxylate pathway. In another aspect of the present invention, the process for the production of glycolic acid from a fermentable carbon source, using a recombinant E. coli, is improved by increasing the NADPH availability in the cells. Optionally the glycolic acid produced can be purified through a step of polymerization to at least glycolic acid dimers and recovered by depolymerisation from glycolic acid dimers, oligomers and/or polymers.